If you’re considering reaching out to BrainChip as a concerned...

If you’re considering reaching out to BrainChip as a concerned shareholder, here are some direct and reasonable questions you might consider putting forward.

These are the kinds of questions any listed company should be prepared — and willing — to answer:

1. Investor Relations (IR) Strategy

• What specific changes have been made to improve investor relations since the AGM?

• When can shareholders expect a consistent schedule of investor updates (e.g., webinars, Q&A sessions, newsletters)?

2. Re-domicile Announcement

• Why was the re-domicile announcement released without prior shareholder consultation or a trading halt if a leak was feared?

• Has the board formally engaged with Australian-based investor relations consultants to address the local market reaction?

3. Commercialisation & Revenue

• What is the updated timeline for first meaningful recurring royalty revenue?

• What happened to the previously stated claim that a single IP deal could make the company cash-flow positive?

4. LDA Capital Agreement

• Why was the LDA drawdown agreement announced on the same day as the redomicile consideration — both being price-sensitive events?

• What alternatives to LDA-style financing were considered and why were they dismissed?

5. Governance and Board Oversight

• What mechanisms are in place to ensure the Board — particularly its U.S.-based members — remains connected to the sentiment of the Australian retail shareholder base?

These are fair, professional questions that deserve honest and timely answers. Silence is not a strategy. Respectfully but persistently asking the right questions is how we hold our company to account — and help it grow stronger.

Let’s start the dialogue. We all want BrainChip to succeed.